Through purpose-driven science, empowering medicines, and transformative advocacy we seek to improve the lives of millions.
Our areas of focus
Endometriosis
An estimated 7.5 million premenopausal women in the U.S. have endometriosis.
Prostate Cancer
Approximately 3 million men alive today in the U.S. have been diagnosed with prostate cancer.
MYOVANT STORIES
Getting a diagnosis for endometriosis can take years. Why does this happen?
View infographic »
A video series on how men with prostate cancer find strength in community.
Watch videos »
Thomasine’s journey through uterine fibroids started with pain but led to empowerment.
Read article »
PURPOSE-DRIVEN SCIENCE
Myovant is developing innovative medicines that hold promise to improve people’s lives.
TRANSFORMATIVE ADVOCACY
We’re partnering with cross-sector coalitions to fight stigma, raise awareness, and empower people with information.
Social Media
News
View more newsEvents
26 Oct 2022
Myovant Sciences Q2 2022 Earnings Conference Call
13 Sep 2022
Baird 2022 Global Healthcare Conference
8 Aug 2022
MYFEMBREE FDA sNDA Approval Conference Call
27 Jul 2022
Myovant Sciences Q1 2022 Earnings Conference Call
STATEMENT
30 Jun 2022
Myovant Statement: U.S. Supreme Court Ruling in Dobbs v. Jackson Women’s Health Organization